Skip to main content
. 2025 Apr 29;12(5):473. doi: 10.3390/bioengineering12050473
AD Alzheimer’s disease
BSI blood-sensitive imaging
CAA cerebral amyloid angiopathy
CVS central vein sign
FLAIR fluid-attenuated inversion recovery
FSBB flow-sensitive black blood
GRE gradient recalled echo
MinIP minimum intensity projection
MRI magnetic resonance imaging
MS multiple sclerosis
MSA multiple system atrophy
PD Parkinson’s disease
PSP progressive supranuclear palsy
QSM quantitative susceptibility mapping
QSMART QSM artifact reduction technique
SWAN susceptibility-weighted angiography
SWI susceptibility-weighted imaging
SWI-p susceptibility-weighted imaging-phase
TE echo time
TR repetition time